Foundation Fighting Blindness Retinal Degeneration Fund
SEC Form 4 insider trading activity
Foundation Fighting Blindness Retinal Degeneration Fund has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company, with disclosures dating back to 2025. 2 of those filings fall inside the rolling window. Most recent filing: May 20, 2026.
On the most recent filing, Foundation Fighting Blindness Retinal Degeneration Fund is listed as Director at Opus Genetics, Inc. Inside the rolling window, Foundation Fighting Blindness Retinal Degeneration Fund reported no open-market purchases and 2 open-market sales totaling $16.0M in IRD. The largest disclosed transaction in the window is a sale of 4,000,000 IRD shares on Dec 9, 2025, worth $8.6M.
Companies traded
Other insiders at IRD
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$16.0M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Foundation Fighting Blindness Retinal Degeneration Fund made?
Foundation Fighting Blindness Retinal Degeneration Fund has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company since 2025.
Which companies does Foundation Fighting Blindness Retinal Degeneration Fund trade?
Foundation Fighting Blindness Retinal Degeneration Fund has filed SEC Form 4 disclosures for 1 company, including IRD.
When was Foundation Fighting Blindness Retinal Degeneration Fund's most recent SEC Form 4 filing?
Foundation Fighting Blindness Retinal Degeneration Fund's most recent SEC Form 4 filing on Tracefour is dated May 20, 2026.
What is Foundation Fighting Blindness Retinal Degeneration Fund's total buy and sell value in the current window?
Inside the rolling retention window, Foundation Fighting Blindness Retinal Degeneration Fund bought $0 and sold $16.0M based on SEC Form 4 filings.
What was Foundation Fighting Blindness Retinal Degeneration Fund's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 4,000,000 IRD shares on 2025-12-09, worth $8.6M, per SEC Form 4 filings.